Andreessen Horowitz, Carlyle Group, and JPMorgan Chase just co-led a $1.05 billion funding round for Castelion, a hypersonic missile startup founded in 2022. The deal closed on August 19, 2026, at a $13 billion post-money valuation, but what matters more than the headline number is the structure: $800 million in equity plus a $250 million revolving credit facility, a debt instrument borrowed from private equity playbooks, not traditional venture capital ones.

When the largest U.S. bank and a buyout firm managing $475 billion in assets both co-lead a venture round alongside a16z, something structural has shifted in how institutional capital thinks about defense technology. This is not a one-off bet. It is a signal that defense tech has completed its transition from niche government contracting into mainstream institutional investment.

What Makes This Deal Structure So Different?

Most venture rounds are straightforward: a startup sells equity, investors get shares, everyone moves on. Castelion's Series C breaks that mold. The revolving credit facility attached to this round is structurally new for early-stage hardware companies. A revolver lets a company draw down, repay, and re-draw capital up to a set limit as working capital demands fluctuate. For a company building physical hypersonic missiles at scale, procuring specialty materials, and staffing a 1,000-acre manufacturing campus in Sandoval County, New Mexico called Project Ranger, cash timing matters in ways that software companies never face. You cannot ship a missile on a delayed purchase order the way you can push a software update. Raw materials must be on hand before production starts.

This hybrid structure reflects a deeper truth: defense hardware requires capital tools that pure venture balance sheets cannot support alone. Private equity firms like Carlyle bring operational experience with large-scale manufacturing, government contracting, and the compliance infrastructure that comes with it. When Castelion eventually navigates ITAR (International Traffic in Arms Regulations, the export control rules governing weapons technology), DCSA facility clearances, and Department of Defense cost accounting standards, having Carlyle's network matters.

Who Are the Investors, and Why Do They Care?

The round was co-led by three institutional heavyweights, each with distinct motivations. Carlyle Group, known for buying mature businesses and improving operations, is not a traditional venture capital firm. Yet its head of Aerospace, Defense and Government practice, Ian Fujiyama, co-led this Series C. His reasoning reveals the broader thesis: "We think there's a multidecade need to rebuild some of that capability that has just atrophied over the years". He is not describing a bet on a single company's product-market fit. He is describing a structural rebuilding of U.S. defense industrial capacity, a thesis with a 20-year horizon that can justify writing checks into early-stage companies where the exit path may be a decade away.

JPMorgan Chase's involvement comes through its Strategic Investment Group, led by Todd Combs, which committed $10 billion over a decade to defense and advanced manufacturing as part of its Security and Resiliency Initiative. For JPMorgan, this is partly strategic positioning: the bank wants to be the financial partner of record when defense-tech companies eventually go public, issue debt, or get acquired. Co-leading a Series C buys relationship capital that converts to lucrative banking mandates later.

Andreessen Horowitz participated through Katherine Boyle, a General Partner who runs a16z's American Dynamism practice, a fund focused on defense, energy, and manufacturing. Participating investors included Lightspeed Venture Partners, Lavrock Ventures, Altimeter Capital, General Catalyst, Interlagos Capital, and T. Rowe Price Associates. That last name matters: T. Rowe Price is a public-market crossover fund, which often signals a company is 18 to 36 months from a public offering.

How Fast Has Castelion's Valuation Grown?

Castelion's $13 billion valuation jumped from a $350 million Series B just eight months earlier, a 37-fold step-up driven by contract backlog and national-security urgency, not traditional revenue multiples. To put this in context, defense-tech venture funding in the first half of 2026 more than doubled to over $12 billion, eclipsing nearly $10 billion raised in all of 2025. Private equity investments in global defense and aerospace exceeded $50 billion in 2025 alone.

Castelion's $13 billion valuation sitting next to Shield AI's $12.7 billion valuation from March 2026 is instructive. These two companies are at roughly equivalent scale by investor perception, despite radically different products. Shield AI focuses on autonomous fighter jet software, a narrower product set than Castelion but a cleaner government-contract-to-revenue story. That convergence suggests the market is pricing defense-tech companies on strategic relevance and contract access, not differentiated revenue models.

What Is Castelion Actually Building?

Castelion was founded in 2022 by three former SpaceX executives: Bryon Hargis (CEO), Sean Pitt, and Andrew Kreitz. Their backgrounds span national-security satellite operations, launch sales, and corporate finance, a deliberate mix built for a company that has to sell to the U.S. government, manufacture hardware, and manage institutional capital simultaneously. The company's flagship program is Blackbeard, a low-cost hypersonic strike missile. Hypersonic weapons travel at Mach 5 or faster (five times the speed of sound), which makes them extremely difficult to intercept with existing air defense systems.

The U.S. military has watched China and Russia field operational hypersonic systems for years while American programs, including ARRW, HACM, and Conventional Prompt Strike, have faced delays, cost overruns, and test failures. Castelion's pitch is that a SpaceX-style manufacturing approach, rapid iteration, cost discipline, and high production volume can close that gap faster than traditional defense contractors. Castelion has existing contracts with the U.S. Department of Defense, though specific contract values and timelines remain classified.

How to Understand This Shift in Defense Tech Funding

• Institutional Capital Entry: Buyout firms and major banks are now co-leading venture rounds in defense tech, bringing debt instruments and operational expertise that pure venture capital cannot provide alone.
• Valuation Acceleration: Defense-tech companies are experiencing 30-fold to 40-fold valuation jumps in short timeframes, driven by government contract backlogs and national-security urgency rather than traditional revenue multiples.
• Structural Capital Needs: Hardware-focused defense companies require hybrid funding structures that combine equity with revolving credit facilities to manage manufacturing timelines and material procurement that software companies do not face.
• Long-Term Thesis: Investors are framing defense-tech bets as multidecade rebuilding efforts of U.S. industrial capacity, not single-company product bets, which justifies 20-year investment horizons.

What Does This Mean for the Broader Defense-Tech Landscape?

The Castelion round is not an isolated event. It is a data point in a larger trend: defense tech has moved from a niche sector where only specialized defense investors operated to a mainstream institutional asset class. Carlyle's involvement signals that traditional private equity sees multidecade value in rebuilding U.S. defense manufacturing. JPMorgan's involvement signals that Wall Street sees profitable banking relationships ahead. a16z's involvement signals that venture capital sees defensible, government-backed revenue streams as attractive as software-as-a-service (SaaS) businesses.

The central risk, however, is opacity. SpaceNews reported that Castelion has existing Department of Defense contracts, but specific contract values and timelines remain classified. That opacity is standard for the defense sector, but it also creates a challenge for investors: you are betting on a company's ability to execute government contracts you cannot fully evaluate. The presence of T. Rowe Price, a public-market crossover fund, suggests investors believe Castelion will eventually go public, at which point more financial transparency will be required. Until then, this round is a bet on the founders' track record, the strategic importance of hypersonic weapons, and the institutional capital's conviction that U.S. defense industrial capacity needs rebuilding.